Multiple roles and mechanisms of MUC6 in cancer (Review)
- Authors:
- Xin Luo
- Xiao Fu
- Ying Xiong
- Ping Xiao
-
Affiliations: Department of General Practice, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330008, P.R. China - Published online on: September 5, 2025 https://doi.org/10.3892/ijmm.2025.5629
- Article Number: 188
-
Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Gendler SJ and Spicer AP: Epithelial mucin genes. Annu Rev Physiol. 57:607–634. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Hollingsworth MA and Swanson BJ: Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer. 4:45–60. 2004. View Article : Google Scholar | |
|
Demouveaux B, Gouyer V, Gottrand F, Narita T and Desseyn JL: Gel-forming mucin interactome drives mucus viscoelasticity. Adv Colloid Interface Sci. 252:69–82. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kohout VR, Wardzala CL and Kramer JR: mirror image mucins and thio mucins with tunable biodegradation. J Am Chem Soc. 145:16573–16583. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Arai J, Hayakawa Y, Tateno H, Murakami K, Hayashi T, Hata M, Matsushita Y, Kinoshita H, Abe S, Kurokawa K, et al: Impaired glycosylation of gastric mucins drives gastric tumorigenesis and serves as a novel therapeutic target. Gastroenterology. 167:505–521 e19. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Perez-Vilar J and Hill RL: The structure and assembly of secreted mucins. J Biol Chem. 274:31751–31754. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Strous GJ and Dekker J: Mucin-type glycoproteins. Crit Rev Biochem Mol Biol. 27:57–92. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Zhao YH, Kalaslavadi TB, Hamati E, Nehrke K, Le AD, Ann DK and Wu R: Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol. 30:155–165. 2004. View Article : Google Scholar | |
|
Higuchi T, Orita T, Nakanishi S, Katsuya K, Watanabe H, Yamasaki Y, Waga I, Nanayama T, Yamamoto Y, Munger W, et al: Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem. 279:1968–1979. 2004. View Article : Google Scholar | |
|
Marimuthu S, Rauth S, Ganguly K, Zhang C, Lakshmanan I, Batra SK and Ponnusamy MP: Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer Metastasis Rev. 40:575–588. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Moniaux N, Escande F, Porchet N, Aubert JP and Batra SK: Structural organization and classification of the human mucin genes. Front Biosci. 6:D1192–D1206. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chaturvedi P, Singh AP and Batra SK: Structure, evolution, and biology of the MUC4 mucin. FASEB J. 22:966–981. 2008. View Article : Google Scholar | |
|
Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M and Batra SK: Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapy. Biochim Biophys Acta. 1815:224–240. 2011.PubMed/NCBI | |
|
Breugelmans T, Oosterlinck B, Arras W, Ceuleers H, De Man J, Hold GL, De Winter BY and Smet A: The role of mucins in gastrointestinal barrier function during health and disease. Lancet Gastroenterol Hepatol. 7:455–471. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Devine PL and McKenzie IF: Mucins: Structure, function, and associations with malignancy. Bioessays. 14:619–625. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Gray T, Koo JS and Nettesheim P: Regulation of mucous differentiation and mucin gene expression in the tracheobronchial epithelium. Toxicology. 160:35–46. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Marzio A, Kurz E, Sahni JM, Di Feo G, Puccini J, Jiang S, Hirsch CA, Arbini AA, Wu WL, Pass HI, et al: EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion. Cell. 185:169–183.e19. 2022. View Article : Google Scholar | |
|
Yang K, Wu J, Xu T, Zhou Y, Liu W and Yang L: Machine learning to predict distant metastasis and prognostic analysis of moderately differentiated gastric adenocarcinoma patients: A novel focus on lymph node indicators. Front Immunol. 15:13986852024. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A, Sun Z, Lai B, Rona G, Zhang J, et al: A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell. 186:3903–3920.e21. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Reily C, Stewart TJ, Renfrow MB and Novak J: Glycosylation in health and disease. Nat Rev Nephrol. 15:346–366. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen K, Gu Y, Cao Y, Fang H, Lv K, Liu X, He X, Wang J, Lin C, Liu H, et al: TIM3(+) cells in gastric cancer: Clinical correlates and association with immune context. Br J Cancer. 126:100–108. 2022. View Article : Google Scholar | |
|
Lai Y, Huang C, Wu J, Yang K and Yang L: Ferroptosis in cancer: A new perspective on T cells. Int Immunopharmacol. 143(Pt 3): 1135392024. View Article : Google Scholar : PubMed/NCBI | |
|
Ratan C, Cicily K D D, Nair B and Nath LR: MUC glycoproteins: Potential biomarkers and molecular targets for cancer therapy. Curr Cancer Drug Targets. 21:132–152. 2021. View Article : Google Scholar | |
|
Liu Y, Tang L, Gao N, Diao Y, Zhong J, Deng Y, Wang Z, Jin G and Wang X: Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects. Oncol Lett. 20:2369–2377. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Guillen-Poza PA, Sánchez-Fernández EM, Artigas G, García Fernández JM, Hinou H, Ortiz Mellet C, Nishimura SI and Garcia-Martin F: Amplified detection of breast cancer autoantibodies using MUC1-based Tn antigen mimics. J Med Chem. 63:8524–8533. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xi X, Wang J, Qin Y, Huang W, You Y and Zhan J: Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy. Cell Death Dis. 13:7082022. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Yin L, Chen S, Li Z, Ding J, Wu J, Yang K and Xu J: The perspectives of NETosis on the progression of obesity and obesity-related diseases: mechanisms and applications. Front Cell Dev Biol. 11:12213612023. View Article : Google Scholar : PubMed/NCBI | |
|
Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ and Kim YS: Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology. 123:1052–1060. 2022. View Article : Google Scholar | |
|
Babu SD, Jayanthi V, Devaraj N, Reis CA and Devaraj H: Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 5:102006. View Article : Google Scholar : PubMed/NCBI | |
|
Dwertmann Rico S, Schliesser SJA, Gorbokon N, Dum D, Menz A, Buscheck F, Hinsch A, Lennartz M, von Bargen C, Bawahab AA, et al: Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors. Pathol Int. 73:281–296. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS, Kelly EJ, Crabtree JE and Ho SB: The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol. 186:398–405. 1998. View Article : Google Scholar | |
|
Fan H, Wu J, Yang K, Xiong C, Xiong S, Wu X, Fang Z, Zhu J and Huang J: Dietary regulation of intestinal stem cells in health and disease. Int J Food Sci Nutr. 74:730–745. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HS, Lee HK, Kim HS, Yang HK, Kim YI and Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: Their roles as prognostic indicators. Cancer. 92:1427–1434. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Freire T, Lo-Man R, Piller F, Piller V, Leclerc C and Bay S: Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Glycobiology. 16:390–401. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Freire T, Lo-Man R, Bay S and Leclerc C: Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J Biol Chem. 286:7797–7811. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Freire T, Bay S, von Mensdorff-Pouilly S and Osinaga E: Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: Putative role of MUC6 in Tn antigen expression. Cancer Res. 65:7880–7887. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tavares C, de Oliveira JT, Lopes C, Carvalheira J, Matos AJ, Rutteman G, Reis CA and Gärtner F: Mucin 6 and Tn antigen expression in canine mammary tumours: Correlation with pathological features. J Comp Pathol. 147:410–418. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Plender EG, Prodanov T, Hsieh P, Nizamis E, Harvey WT, Sulovari A, Munson KM, Kaufman EJ, O'Neal WK, Valdmanis PN, et al: Structural and genetic diversity in the secreted mucins MUC5AC and MUC5B. Am J Hum Genet. 111:1700–1716. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Gendler SJ, Burchell JM, Duhig T, Lamport D, White R, Parker M and Taylor-Papadimitriou J: Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci USA. 84:6060–6064. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Gum JR Jr, Hicks JW, Toribara NW, Rothe EM, Lagace RE and Kim YS: The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem. 267:21375–21383. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, Gum JR Jr, Byrd JC, Siddiki B and Kim YS: Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem. 268:5879–5885. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Lang T: Tandem repeats structure of gel-forming mucin domains could be revealed by SMRT sequencing data. Sci Rep. 12:206522022. View Article : Google Scholar : PubMed/NCBI | |
|
Karbhari DS, Panwalla NM, Mondkar AM and Motashaw ND: Eclampsia-the influence of antenatal care. J Postgrad Med. 18:175–180. 1972.PubMed/NCBI | |
|
Kornfeld R and Kornfeld S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 54:631–664. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarz F and Aebi M: Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 21:576–582. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ruddock LW and Molinari M: N-glycan processing in ER quality control. J Cell Sci. 119(Pt 21): 4373–4380. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Stanley P: Golgi glycosylation. Cold Spring Harb Perspect Biol. 3:a0051992011. View Article : Google Scholar : PubMed/NCBI | |
|
Marth JD: Complexity in O-linked oligosaccharide biosynthesis engendered by multiple polypeptide N-acetylgalactosaminyltransferases. Glycobiology. 6:701–705. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Rose MC and Voynow JA: Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 86:245–278. 2006. View Article : Google Scholar | |
|
Kasprzak A and Adamek A: Mucins: The old, the new and the promising factors in hepatobiliary carcinogenesis. Int J Mol Sci. 20:12882019. View Article : Google Scholar : PubMed/NCBI | |
|
Van Acker SI, Van den Bogerd B, Van Acker ZP, Vailionytė A, Haagdorens M, Koppen C, Ní Dhubhghaill S, Dartt DA and Pintelon I: Characterisation of gel-forming mucins produced in vivo and in ex vivo conjunctival explant cultures. Int J Mol Sci. 22:105282021. View Article : Google Scholar : PubMed/NCBI | |
|
Rousseau K, Byrne C, Kim YS, Gum JR, Swallow DM and Toribara NW: The complete genomic organization of the human MUC6 and MUC2 mucin genes. Genomics. 83:936–939. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Desseyn JL, Aubert JP, Porchet N and Laine A: Evolution of the large secreted gel-forming mucins. Mol Biol Evol. 17:1175–1184. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kwon JA, Lee SY, Ahn EK, Seol SY, Kim MC, Kim SJ, Kim SI, Chu IS and Leem SH: Short rare MUC6 minisatellites-5 alleles influence susceptibility to gastric carcinoma by regulating gene. Hum Mutat. 31:942–949. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Han HS, Lee SY, Lee KY, Hong SN, Kim JH, Sung IK, Park HS, Jin CJ and Min YI: Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness. J Gastroenterol Hepatol. 24:658–666. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Leir SH and Harris A: MUC6 mucin expression inhibits tumor cell invasion. Exp Cell Res. 317:2408–2419. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lidell ME, Johansson ME and Hansson GC: An autocatalytic cleavage in the C terminus of the human MUC2 mucin occurs at the low pH of the late secretory pathway. J Biol Chem. 278:13944–13951. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K and Augenlicht L: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 295:1726–1729. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Toribara NW, Ho SB, Gum E, Gum JR Jr, Lau P and Kim YS: The carboxyl-terminal sequence of the human secretory mucin, MUC6. Analysis Of the primary amino acid sequence. J Biol Chem. 272:16398–16403. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Cozzi PJ, Wang J, Delprado W, Perkins AC, Allen BJ, Russell PJ and Li Y: MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin Exp Metastasis. 22:565–573. 2005. View Article : Google Scholar | |
|
Senapati S, Sharma P, Bafna S, Roy HK and Batra SK: The MUC gene family: Their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol. 23:1541–1552. 2008.PubMed/NCBI | |
|
Boccellato F, Woelffling S, Imai-Matsushima A, Sanchez G, Goosmann C, Schmid M, Berger H, Morey P, Denecke C, Ordemann J and Meyer TF: Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection. Gut. 68:400–413. 2019. View Article : Google Scholar | |
|
Yuki A, Fujii C, Yamanoi K, Matoba H, Harumiya S, Kawakubo M and Nakayama J: Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy. Cancer Sci. 113:576–586. 2022. View Article : Google Scholar | |
|
Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M and Yonezawa S: Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 14:243–254. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Prasad NB, Biankin AV, Fukushima N, Maitra A, Dhara S, Elkahloun AG, Hruban RH, Goggins M and Leach SD: Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 65:1619–1626. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E and Yonezawa S: Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: Comparison with invasive ductal carcinoma. Histopathology. 42:26–36. 2003. View Article : Google Scholar | |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015.PubMed/NCBI | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI | |
|
Ding JT, Yang KP, Zhou HN, Huang YF, Li H and Zong Z: Landscapes and mechanisms of CD8(+) T cell exhaustion in gastrointestinal cancer. Front Immunol. 14:11496222023. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Qi H, Li Z, Bao Y, Yang K and Min Q: Research progress on the premature ovarian failure caused by cisplatin therapy. Front Oncol. 13:12763102023. View Article : Google Scholar : PubMed/NCBI | |
|
Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 61:1–241. 1994.PubMed/NCBI | |
|
Nguyen TV, Janssen M Jr, Gritters P, te Morsche RH, Drenth JP, van Asten H, Laheij RJ and Jansen JB: Short mucin 6 alleles are associated with H pylori infection. World J Gastroenterol. 12:6021–6025. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T and Nakayama J: Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science. 305:1003–1006. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM and Bresalier RS: Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology. 113:455–464. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Van den Brink GR, Tytgat KM, Van der Hulst RW, Van der Loos CM, Einerhand AW, Buller HA and Dekker J: H pylori colocalises with MUC5AC in the human stomach. Gut. 46:601–607. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Jia Y, Persson C, Hou L, Zheng Z, Yeager M, Lissowska J, Chanock SJ, Chow WH and Ye W: A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control. 21:313–321. 2010. | |
|
Khattab AZ, Nasif WA and Lotfy M: MUC2 and MUC6 apomucins expression in human gastric neoplasm: An immunohistochemical analysis. Med Oncol. 28(Suppl 1): S207–S213. 2011. View Article : Google Scholar | |
|
Marin F, Bonet C, Munoz X, Garcia N, Pardo ML, Ruiz-Liso JM, Alonso P, Capellà G, Sanz-Anquela JM, González CA and Sala N: Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain. Carcinogenesis. 33:1072–1080. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L and Pimenta A: Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 440:304–310. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pinto-de-Sousa J, Reis CA, David L, Pimenta A and Cardoso-de-Oliveira M: MUC5B expression in gastric carcinoma: Relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch. 444:224–230. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Reis CA, David L, Carvalho F, Mandel U, de Bolos C, Mirgorodskaya E, Clausen H and Sobrinho-Simões M: Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem. 48:377–388. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K and Kitano S: Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int. 54:311–321. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Barua RR, Uozaki H, Chong JM, Ushiku T, Hino R, Chang MS, Nagai H and Fukayama M: Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma. J Gastroenterol. 41:733–739. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tjandra D, Busuttil RA and Boussioutas A: Gastric intestinal metaplasia: Challenges and the opportunity for precision prevention. Cancers (Basel). 15:39132023. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: An immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol. 132:817–823. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Oosterlinck B, Ceuleers H, Arras W, De Man JG, Geboes K, De Schepper H, Peeters M, Lebeer S, Skieceviciene J, Hold GL, et al: Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer. Microbiome. 11:862023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Peng Y, Ding Y, Liu Y, Wang Y, Liu Y and Liu C: The clinicopathological and molecular characteristics of endocervical gastric-type adenocarcinoma and the use of claudin18.2 as a potential therapeutic target. Mod Pathol. 37:1005692024. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Ciarpaglini C, Barros R, Caballero C, Boggino H, Alarcon-Molero L, Peleteiro B, Ruiz-García E, Fernandez-Figueroa E, Herrera-Goepfert R, Díaz-Romero C, et al: Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression. Gastric Cancer. 28:160–173. 2025. View Article : Google Scholar : PubMed/NCBI | |
|
Garcia E, Carvalho F, Amorim A and David L: MUC6 gene polymorphism in healthy individuals and in gastric cancer patients from northern Portugal. Cancer Epidemiol Biomarkers Prev. 6:1071–1074. 1997. | |
|
Dashti F, Mirazimi SMA, Rabiei N, Fathazam R, Rabiei N, Piroozmand H, Vosough M, Rahimian N, Hamblin MR and Mirzaei H: The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Mol Ther Nucleic Acids. 26:892–926. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Rohani Borj M, Pourghadamyari H, Rahimian N, Hamblin MR and Mirzaei H: Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 161:314–327. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Aghdam AM, Amiri A, Salarinia R, Masoudifar A, Ghasemi F and Mirzaei H: MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate cancer. Crit Rev Eukaryot Gene Expr. 29:127–139. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL, Jenkins MA, et al: Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol. 26:1642–1656. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka Y, Eizuka M, Uesugi N, Kawasaki K, Yamano H, Suzuki H, Matsumoto T and Sugai T: Traditional serrated adenoma has two distinct genetic pathways for molecular tumorigenesis with potential neoplastic progression. J Gastroenterol. 55:846–857. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bartley AN, Thompson PA, Buckmeier JA, Kepler CY, Hsu CH, Snyder MS, Lance P, Bhattacharyya A and Hamilton SR: Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Mod Pathol. 23:169–176. 2010. View Article : Google Scholar | |
|
Gibson JA, Hahn HP, Shahsafaei A and Odze RD: MUC expression in hyperplastic and serrated colonic polyps: Lack of specificity of MUC6. Am J Surg Pathol. 35:742–749. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Owens SR, Chiosea SI and Kuan SF: Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol. 21:660–669. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ahn MH, Bae KB, Kwon JA, Choi HJ, Lee SR, Kim SH, Jung TD, Kim SH, An MS, Hong KH, et al: Association of MUC6-minisatellite variants with susceptibility to rectal carcinoma. Mol Biol Rep. 40:303–308. 2013. View Article : Google Scholar | |
|
Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, et al: Advances in cholangiocarcinoma research: Report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol. 7:819–827. 2016. View Article : Google Scholar | |
|
Thuwajit P, Chawengrattanachot W, Thuwajit C, Sripa B, Paupairoj A and Chau-In S: Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival. J Gastroenterol Hepatol. 23:771–778. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y and Tsuneyoshi M: Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology. 49:35–44. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG and Moon WS: Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: Prognostic impact. Oncol Rep. 22:649–657. 2009.PubMed/NCBI | |
|
Albores-Saavedra J, Chable-Montero F, Gonzalez-Romo MA, Ramirez Jaramillo M and Henson DE: Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma. Hum Pathol. 43:1506–1513. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nagata S, Ajioka Y, Nishikura K, Watanabe G, Inoue T, Yamaguchi K, Watanabe H, Tanaka M and Tsuneyoshi M: Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: Immunohistochemical analysis of mucin profile and CD10. Oncol Rep. 17:721–729. 2007.PubMed/NCBI | |
|
Sasaki M, Yamato T, Nakanuma Y, Ho SB and Kim YS: Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Int. 49:38–44. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Sato K, Ito E, Masaki Y and Ogawa M: A case report of gallbladder cancer and pancreas cystic neoplasm associated with pancreaticobiliary maljunction. Int J Surg Case Rep. 85:1061702021. View Article : Google Scholar : PubMed/NCBI | |
|
Carrasco C, Tittarelli A, Paillaleve N, Pozo MD, Rojas-Sepulveda D, Barria O, Fluxá P, Hott M, Martin C, Quezada C and Salazar-Onfray F: The evaluation of 17 gastrointestinal tumor markers reveals prognosis value for MUC6, CK17, and CD10 in gallbladder-cancer patients. Diagnostics (Basel). 11:1532021. View Article : Google Scholar : PubMed/NCBI | |
|
Kamisawa T, Wood LD, Itoi T and Takaori K: Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rawla P, Sunkara T and Gaduputi V: Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu DF, Wang LS and Zhou JH: Long noncoding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR24/MUC6 axis. Int J Oncol. 56:494–507. 2020.PubMed/NCBI | |
|
Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchene B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N and Van Seuningen I: miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Oncogene. 34:780–788. 2015. View Article : Google Scholar | |
|
Mohr AM, Bailey JM, Lewallen ME, Liu X, Radhakrishnan P, Yu F, Tapprich W and Hollingsworth MA: MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. PLoS One. 8:e733062013. View Article : Google Scholar : PubMed/NCBI | |
|
Basturk O, Khayyata S, Klimstra DS, Hruban RH, Zamboni G, Coban I and Adsay NV: Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol. 34:364–370. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama Y, Tani M, Takizawa T, Koike M and Yuasa Y: Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 24:257–263. 2004.PubMed/NCBI | |
|
Sakai H, Jinawath A, Yamaoka S and Yuasa Y: Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors. Biochem Biophys Res Commun. 333:1254–1260. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, et al: Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Res. 66:1025–1032. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lee CS, Sund NJ, Vatamaniuk MZ, Matschinsky FM, Stoffers DA and Kaestner KH: Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes. 51:2546–2551. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sierzega M, Mlynarski D, Tomaszewska R and Kulig J: Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance. Histopathology. 69:582–591. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jinfeng M, Kimura W, Hirai I, Sakurai F, Moriya T and Mizutani M: Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis. Int J Gastrointest Cancer. 34:9–18. 2003. View Article : Google Scholar | |
|
Awaya H, Takeshima Y, Yamasaki M and Inai K: Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Am J Clin Pathol. 121:644–653. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pereira MB, Dias AJ, Reis CA and Schmitt FC: Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues. J Clin Pathol. 54:210–213. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Do SI, Kim K, Kim DH, Chae SW, Park YL, Park CH and Sohn JH: Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and clinicopathologic parameters of human breast ductal carcinomas. J Breast Cancer. 16:152–158. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Oral O, Unverdi H, Kumcu E, Turkbey D, Dogan S and Hucumenoglu S: Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas. Indian J Pathol Microbiol. 63:551–558. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF and Ellis IO: Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol. 18:1295–1304. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
de Bolos C, Guma M, Barranco C, Garrido M, Kim YS and Real FX: MUC6 expression in breast tissues and cultured cells: abnormal expression in tumors and regulation by steroid hormones. Int J Cancer. 77:193–199. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Buyuk M, Ozluk Y, Bakkaloglu DV, Ozkan B, Firat P and Yilmazbayhan D: Evaluation of MUC1, MUC2, MUC5AC, and MUC6 expression differences in lung adenocarcinoma subtypes by using a final immunoreactivity score (FIRS). Turk Patoloji Derg. 39:64–74. 2023. | |
|
Copin MC, Buisine MP, Leteurtre E, Marquette CH, Porte H, Aubert JP, Gosselin B and Porchet N: Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas. Hum Pathol. 32:274–281. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hamamoto A, Abe Y, Nishi M, Fujimori S, Ohnishi Y, Yamazaki H, Oida Y, Miyazaki N, Inada K, Ueyama Y, et al: Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts. Int J Oncol. 26:891–896. 2005.PubMed/NCBI | |
|
Kishikawa S, Hayashi T, Saito T, Takamochi K, Kohsaka S, Sano K, Sasahara N, Sasa K, Kurihara T, Hara K, et al: Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma. Mod Pathol. 34:786–797. 2021. View Article : Google Scholar | |
|
Lee HK, Kwon MJ, Seo J, Kim JW, Hong M, Park HR, Min SK, Choe JY, Ra YJ, Jang SH, et al: Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer. Pathol Res Pract. 215:459–465. 2019. View Article : Google Scholar | |
|
Rerkpichaisuth V, Lau RP, Meyerson C and Fishbein GA: The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma. Hum Pathol. 151:1056272024. View Article : Google Scholar : PubMed/NCBI | |
|
Nishiumi N, Abe Y, Inoue Y, Hatanaka H, Inada K, Kijima H, Yamazaki H, Tatematsu M, Ueyama Y, Iwasaki M, et al: Use of 11p15 mucins as prognostic factors in small adenocarcinoma of the lung. Clin Cancer Res. 9:5616–5619. 2003.PubMed/NCBI | |
|
Rahimian N, Razavi ZS, Aslanbeigi F, Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR and Mirzaei H: Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol. 161:896–912. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Leroy X, Ballereau C, Villers A, Saint F, Aubert S, Gosselin B, Porchet N and Copin MC: MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma. Am J Surg Pathol. 27:519–521. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kudryavtseva AV, Lukyanova EN, Kharitonov SL, Nyushko KM, Krasheninnikov AA, Pudova EA, Guvatova ZG, Alekseev BY, Kiseleva MV, Kaprin AD, et al: Bioinformatic identification of differentially expressed genes associated with prognosis of locally advanced lymph node-positive prostate cancer. J Bioinform Comput Biol. 17:19500032019. View Article : Google Scholar : PubMed/NCBI | |
|
Schaid DJ, McDonnell SK, FitzGerald LM, DeRycke L, Fogarty Z, Giles GG, MacInnis RJ, Southey MC, Nguyen-Dumont T, Cancel-Tassin G, et al: Two-stage study of familial prostate cancer by whole-exome sequencing and custom capture identifies 10 novel genes associated with the risk of prostate cancer. Eur Urol. 79:353–361. 2021. View Article : Google Scholar : | |
|
Sarvizadeh M, Hasanpour O, Naderi Ghale-Noie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, Masoud Khooy M, Aschner M, Khan H, Rezaei N, et al: Allicin and digestive system cancers: From chemical structure to its therapeutic opportunities. Front Oncol. 11:6502562021. View Article : Google Scholar : PubMed/NCBI | |
|
Savardashtaki A, Shabaninejad Z, Movahedpour A, Sahebnasagh R, Mirzaei H and Hamblin MR: miRNAs derived from cancer-associated fibroblasts in colorectal cancer. Epigenomics. 11:1627–1645. 2016. View Article : Google Scholar | |
|
Urick ME and Bell DW: Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, Hamblin MR and Mirzaei H: Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 157:1031922021. View Article : Google Scholar | |
|
Hodgson A, Parra-Herran C and Mirkovic J: Immunohistochemical expression of HIK1083 and MUC6 in endometrial carcinomas. Histopathology. 75:552–558. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fulgione C, Raffone A, Travaglino A, Arciuolo D, Santoro A, Cianfrini F, Russo D, Varricchio S, Raimondo I, Inzani F, et al: Diagnostic accuracy of HIK1083 and MUC6 as immunohistochemical markers of endocervical gastric-type adenocarcinoma: A systematic review and meta-analysis. Pathol Res Pract. 241:1542612023. View Article : Google Scholar | |
|
Alameda F, Mejias-Luque R, Garrido M and de Bolos C: Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues. Int J Gynecol Pathol. 26:61–65. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Carbone FR and Gleeson PA: Carbohydrates and antigen recognition by T cells. Glycobiology. 7:725–730. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Cloos PA and Christgau S: Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology. 5:139–158. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kontani K, Taguchi O, Narita T, Izawa M, Hiraiwa N, Zenita K, Takeuchi T, Murai H, Miura S and Kannagi R: Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes. Br J Cancer. 84:1258–1264. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hoshi H, Sawada T, Uchida M, Iijima H, Kimura K, Hirakawa K and Wanibuchi H: MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways. Int J Oncol. 42:887–893. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas A and Giaccone G: Why has active immunotherapy not worked in lung cancer? Ann Oncol. 26:2213–2220. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Padilla MT, Li B, Wells A, Kato K, Tellez C, Belinsky SA, Kim KC and Lin Y: MUC1 in macrophage: Contributions to cigarette smoke-induced lung cancer. Cancer Res. 74:460–470. 2014. View Article : Google Scholar | |
|
Pelosi G and Sonzogni A: MUC6 distribution in the spectrum of pulmonary mucinous adenocarcinoma. Mod Pathol. 35:2025–2026. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Hoshi H, Sawada T, Uchida M, Saito H, Iijima H, Toda-Agetsuma M, Wada T, Yamazoe S, Tanaka H, Kimura K, et al: Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer. Int J Oncol. 38:619–627. 2011.PubMed/NCBI | |
|
Slovin SF, Ragupathi G, Musselli C, Olkiewicz K, Verbel D, Kuduk SD, Schwarz JB, Sames D, Danishefsky S, Livingston PO and Scher HI: Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: Clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine. J Clin Oncol. 21:4292–4298. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kang S, Bae MJ, Kang MK, Kim H, Kang YR, Jo WS, Lee CG, Jung B, Lee J, Moon C, et al: Possible association of G6PC2 and MUC6 induced by low-dose-rate irradiation in mouse intestine with inflammatory bowel disease. Mol Med Rep. 30:1272024. View Article : Google Scholar | |
|
Cin M, Gundogar O, Yarikkaya E and Cin S: The importance of MUC6 immunohistochemistry staining in the histopathologic examination of Crohn's disease: Can we enhance our diagnostic power? Ann Diagn Pathol. 78:1524822025. View Article : Google Scholar : PubMed/NCBI | |
|
Wong N, Beavers S, Gill P, Heryet A and Linares J: Calponin and MUC6 complement inhibin as diagnostic immunomarkers of serous cystadenoma in endoscopic ultrasound-guided aspiration/biopsy specimens. Histopathology. 79:252–259. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yamada S, Yamanoi K, Sato Y and Nakayama J: Diffuse MIST1 expression and decreased alpha1,4-linked N-acetylglucosamine (alphaGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation. Histopathology. 77:413–422. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong F, Ren Z, Li W, Jones T, Zeng X, Wang S, Tao X and Zhao C: The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions. Hum Pathol. 160:1058372025. View Article : Google Scholar : PubMed/NCBI | |
|
Shi H, Zhang W, Hu B, Wang Y, Zhang Z, Sun Y, Mao G, Li C and Lu S: Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatol Int. 17:393–405. 2023. View Article : Google Scholar | |
|
Kim GH, Lee JS, Lee JH and Park YS: Oxyntic gland neoplasms - from adenoma to advanced gastric cancer: A review of 29 cases. J Gastric Cancer. 24:378–390. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Kurosawa T, Murakami T, Yamashiro Y, Terukina H, Hayashi T, Saito T, Nojiri S, Sakamoto K, Nagahara A and Yao T: Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation. Pathol Res Pract. 232:1538402022. View Article : Google Scholar : PubMed/NCBI | |
|
Tanabe H, Uehara T and Ota H: Cell lineage-specific immunohistochemical markers in biliary intraepithelial neoplasia: Implications for subclassification and grading. Pathol Res Pract. 269:1558962025. View Article : Google Scholar : PubMed/NCBI | |
|
Riley NM, Wen RM, Bertozzi CR, Brooks JD and Pitteri SJ: Measuring the multifaceted roles of mucin-domain glycoproteins in cancer. Adv Cancer Res. 157:83–121. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta R, Ponangi R and Indresh KG: Role of glycosylation in breast cancer progression and metastasis: Implications for miRNA, EMT and multidrug resistance. Glycobiology. 33:545–555. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Costa VD, Marino KV, Rodriguez-Zraquia SA, Festari MF, Lores P, Costa M, Landeira M, Rabinovich GA, van Vliet SJ and Freire T: Lung tumor cells with different Tn antigen expression present distinctive immunomodulatory properties. Int J Mol Sci. 23:120472022. View Article : Google Scholar : PubMed/NCBI | |
|
Iwaya M, Kodama M, Abe K, Maeda K, Nakajima T, Uehara T, Nishio R, Yamana T, Riddell R, Ota H, et al: Variability in morphology and immunohistochemistry of Crohn's disease-associated small bowel neoplasms: Implications of Claudin 18 and Cadherin 17 expression for tumor-targeted immunotherapies. Virchows Arch. 486:595–603. 2025. View Article : Google Scholar | |
|
Yang Y, Akashi Y, Shimomura O, Tateno H, Saito S, Hiemori K, Miyazaki Y, Furuta T, Kitaguchi D, Kuroda Y, et al: Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy. Gastric Cancer. 25:896–905. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ideo H, Tsuchida A and Takada Y: Lectin-based approaches to analyze the role of glycans and their clinical application in disease. Int J Mol Sci. 25:102312024. View Article : Google Scholar : PubMed/NCBI |
